Jan D Bos Selected Research

Jan D Bos Research Topics

Disease

21	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2012 - 11/2002
11	Atopic Dermatitis (Atopic Eczema) 01/2018 - 01/2002
6	Inflammation (Inflammations) 01/2018 - 10/2002
4	Psoriatic Arthritis 09/2012 - 10/2002
3	Hyperpigmentation 10/2012 - 09/2010
3	Pruritus (Itching) 06/2012 - 02/2006
3	Melanoma (Melanoma, Malignant) 09/2011 - 05/2010
3	Infections 11/2008 - 07/2002
2	Eczema 03/2014 - 07/2002
2	Erythema 10/2012 - 03/2011
2	Skin Diseases (Skin Disease) 03/2012 - 01/2002
2	Neoplasms (Cancer) 09/2011 - 05/2010
2	Melanosis (Freckles) 03/2011 - 09/2010
2	Hypersensitivity (Allergy) 08/2008 - 02/2006
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2013
1	Fibrosis (Cirrhosis) 03/2012
1	Nevus (Nevi) 12/2011
1	Vitiligo 06/2011
1	Edema (Dropsy) 03/2011
1	Pain (Aches) 03/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2010
1	Cutaneous Lupus Erythematosus 10/2010
1	Allergic Contact Dermatitis 01/2009
1	Hypopigmentation (Hypomelanosis) 11/2006
1	Neurogenic Inflammation 02/2006
1	Fatigue 01/2006
1	Sunburn 01/2005
1	Contact Dermatitis (Eczema, Contact) 07/2004
1	Necrosis 01/2004

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 09/2012 - 01/2002
5	Proteins (Proteins, Gene)FDA Link 09/2012 - 04/2002
4	Melanins (Melanin)IBA 10/2012 - 01/2005
4	AntigensIBA 09/2012 - 05/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2010 - 04/2002
3	Filaggrin ProteinsIBA 03/2014 - 04/2010
3	Alefacept (Amevive)FDA Link 09/2012 - 10/2002
3	Etanercept (Enbrel)FDA Link 08/2010 - 01/2006
3	pimecrolimus (Elidel)FDA Link 01/2007 - 01/2002
3	Methotrexate (Mexate)FDA LinkGeneric 06/2004 - 08/2003
2	AllergensIBA 01/2018 - 03/2008
2	Adalimumab (Humira)FDA Link 01/2012 - 02/2010
2	Monophenol Monooxygenase (Tyrosinase)IBA 09/2011 - 06/2011
2	Differentiation AntigensIBA 09/2011 - 06/2011
2	monobenzone (Benoquin)FDA Link 06/2011 - 05/2010
2	Therapeutic UsesIBA 05/2010 - 04/2003
2	Infliximab (Remicade)FDA Link 08/2008 - 01/2004
2	Complement System Proteins (Complement)IBA 04/2007 - 02/2006
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2004 - 08/2003
2	Biological ProductsIBA 01/2004 - 11/2002
2	Interleukin-4 (Interleukin 4)IBA 01/2003 - 04/2002
1	Thyroid HormonesIBA 01/2013
1	interleukin 20 (IL-20)IBA 09/2012
1	InterleukinsIBA 06/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Dihydrotachysterol (AT 10)IBA 12/2011
1	Peptides (Polypeptides)IBA 09/2011
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 09/2011
1	quinone (benzoquinone)IBA 06/2011
1	HaptensIBA 06/2011
1	hydroquinone (Esoterica)FDA Link 03/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2011
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2011
1	Interleukin-22 (IL-22)IBA 11/2010
1	Interleukin-17 (Interleukin 17)IBA 11/2010
1	N-phthaloylglutamic acidIBA 09/2010
1	Prostaglandins AIBA 09/2010
1	Pancreatic Elastase (Elastase)IBA 08/2010
1	Skin Lightening PreparationsIBA 05/2010
1	Imiquimod (Aldara)FDA LinkGeneric 05/2010
1	AntibodiesIBA 02/2010
1	Interleukin-12 (IL 12)IBA 11/2008
1	GlucocorticoidsIBA 09/2008
1	Vitamin D FDA LinkGeneric 09/2008
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2008
1	Immunoglobulin E (IgE)IBA 03/2008
1	LigandsIBA 09/2007
1	CCR5 Receptors (CCR5 Receptor)IBA 09/2007
1	Chemokine ReceptorsIBA 09/2007
1	Chemokine CCL5IBA 09/2007
1	AncrivirocIBA 09/2007
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2007
1	Clindamycin (Cleocin)FDA LinkGeneric 11/2006
1	Benzoyl Peroxide FDA LinkGeneric 11/2006
1	Fluticasone (Cutivate)FDA LinkGeneric 11/2006
1	efalizumab (Raptiva)FDA Link 04/2006
1	Interleukin-23 (Interleukin 23)IBA 02/2006
1	E-SelectinIBA 08/2005
1	Urocanic AcidIBA 07/2004
1	Picryl Chloride (Trinitrochlorobenzene)IBA 07/2004
1	Pharmaceutical PreparationsIBA 04/2004

Therapy/Procedure

14	Therapeutics 01/2012 - 08/2003
5	Laser Therapy (Surgery, Laser) 10/2012 - 09/2010
4	Lasers (Laser) 10/2012 - 09/2010
3	Immunotherapy 09/2011 - 05/2010
1	Aftercare (After-Treatment) 09/2012
1	Rejuvenation 03/2012
1	Withholding Treatment 05/2010
1	Ligation 07/2004
1	Duration of Therapy 03/2004
1	Remission Induction 03/2004